Encora Therapeutics

For your independence

Boston, United States · Founded 2018 · $1.5M raised

Employees
1–10
Founded
2018
Business Model
B2B
Total Funding
$1.5M
Last Round
$1.5M SeedSep 2020
Rounds
1

About

Encora Therapeutics is a clinical-stage medtech company developing non-invasive neuromodulation wearable devices to treat neurological movement disorders, particularly essential tremor and Parkinson's disease. Its flagship product, the Encora X1, received FDA 510(k) clearance in February 2026 — following Breakthrough Device Designation in 2021 — and uses proprietary algorithms to analyze a patient's tremors in real time, delivering targeted electrical stimulation to the wrist to disrupt the tremor signal. Founded in 2018 by Daniel Carballo, Allison Davanzo, and Kyle Pina, Encora is based in Boston, Massachusetts and is a resident company of MIT's The Engine deep tech accelerator.

Summary

Encora Therapeutics is a Biotech company based in Boston, United States, founded in 2018. It has raised $1.5M in total across 1 round, most recently a $1.5M Seed round in Sep 2020. Investors include Innospark Ventures, Good Growth Capital and The Engine.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundSep 2020
$1.5M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Encora Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/encora-therapeutics"><img src="https://indexed.vc/api/badge/company/encora-therapeutics" alt="Encora Therapeutics on Indexed.vc" width="260" height="76" /></a>